Elevated levels of NANOG have been observed in a variety of cancers, and are observed to be regulated by post translational modifications, specifically phosphorylation [9], Recent studies have observed distinct mechanisms by which high expressions of NANOG promotes tumorigenesis, including the ability for immune evasion [10]. The gene discussed is NANOG; the disease is cancer.